AMRN icon

AMRN

Lightning icon

15.22 USD

+0.60%

Today

-0.40%

1D

Market is open

Sun

Closed

Mon

3:00 AM ~ 12:00 PM

Tue

12:00 AM ~ 12:00 PM

Wed

12:00 AM ~ 12:00 PM

Thu

12:00 AM ~ 12:00 PM

Fri

12:00 AM ~ 12:00 PM

Sat

Closed

Loading chart...
1D
5D
1M
3M
1Y
MAX

Information

Name

Amarin Corp PLC Leveraged

Currency

USD

Standard Leverage

1X

Lightning Icon

Enhanced Leverage

3X

Lightning Icon

Overnight Fees Buy

-0.0183%

Overnight Fees Sell

0.0016%

Market Cap

333.62M

Avg Daily Volume

102.39K

52 Week High

20.9 USD

52 Week Low

12.96 USD

Trading Hours

See hours

Overnight Fees Calculator

ExposureUnits
USD
Daily Overnight Fee %Daily Overnight Fee $
BUYS-0.01830%$(0.183)
SELLS0.00160%$0.016

*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.

Business Summary

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Top News

Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape

tradingview.com

1w ago

No Image

New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia

tradingview.com

1mo ago

No Image

AmAirlines

-0.06%

AbbottLabs

+0.32%

Aehr.Systems

-3.90%

AmgenInc

+0.22%

Amarin

-0.40%

Apollo

-0.84%

AxonEnterprise

+0.31%

BOAmerica

+0.73%

Beyond.Inc

-0.37%

BookingHld

+0.04%

BioXcel

+6.49%

Blackstone

+0.87%

Coeur

-0.13%

CFIndustries

+0.88%

Chegg

+0.00%

Chewy

+1.66%

Clean.Spark

+1.01%

Coinbase

+4.51%

Chevron

+0.53%

Delta

-1.22%

Deere

+0.25%

DR_Horton

+0.29%

Devon

+0.21%

ElancoAnimal

-2.60%

Elevance-Health-Inc

-3.68%

Expedia

-0.80%

Freeport_Mcmoran

+0.07%

GATX_Corp

-0.51%

Greenbrier

-1.14%

GileadSci

-0.09%

GoldmanSachs

+0.55%

HimsandHers.Inc

+0.59%

Hecla.Mining

-0.63%

Humana

+0.98%

IDEXXLab

+0.56%

Insmed

+0.25%

JBHunt

+1.26%

JPMorgan

+0.86%

KKR&Co

+0.75%

Lennar

-0.20%

Levi.Strauss

+0.17%

Southwest

+0.08%

Mosaic

+0.00%

MicroStrategy

+4.40%

NorwegianCruise

+0.71%

NewmontM

+0.19%

Novavax

+0.75%

Opko

+1.49%

Occidental

+0.92%

PulteGroup

+0.21%

ProQR.Therapeutics

+0.58%

SouthernCopper

-0.55%

Scorpio.Tankers

+2.01%

TollBrothers

+2.01%

UnitySoftware

+4.27%

UnitedCon

-0.37%

UnitedHlt

+0.49%

ViaSat

+0.43%

Westinghouse

-1.63%

WellsFargo

+0.52%

ExxonMobil

+0.50%

ZoetisInc

+0.43%

BUZZ-U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg

reuters.com

3mo ago

No Image

Show more

Frequently Asked Questions

What are healthcare stocks and why are they important to investors?

Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.


Are healthcare stocks less volatile?

Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.


What drives growth in healthcare investments?

Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.


What are the risks of investing in healthcare?

Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.